Congenital heart disease (CHD) is often comprised of complex three-dimensional (3D) anatomy that must be well understood to assess the pathophysiological consequences and guide therapy. Thus, detailed cardiac imaging for early detection and planning of interventional and/or surgical treatment is paramount. Advanced technologies have revolutionized diagnostic and therapeutic practice in CHD, thus playing an increasing role in its management. Traditional reliance on standard imaging modalities including echocardiography, cardiac computed tomography (CT) and magnetic resonance imaging (MRI) has been augmented by the use of recent technologies such as 3D printing, virtual reality, augmented reality, computational modelling, and artificial intel...
Three-dimensional (3D) printing has become a widely used technique showing great promise in medical ...
Abstract Congenital heart diseases causing significant hemodynamic and functional cons...
Background: 3D technology support is an emerging technology in the field of congenital heart disease...
Congenital heart disease (CHD) is often comprised of complex three-dimensional (3D) anatomy that mus...
Congenital heart disease (CHD) is often comprised of complex three-dimensional (3D) anatomy that mus...
Patient-specific three-dimensional (3D) printed models have been increasingly used in cardiology and...
Three-dimensional (3D) printing has shown great promise in medicine with increasing reports in conge...
Echocardiography, CT and MRI have a crucial role in the management of congenital heart disease (CHD)...
Three-dimensional (3D) printing technology has become increasingly used in the medical field, with r...
Understanding the anatomical features and generation of realistic three-dimensional (3D) visualizati...
Abstract Beginning with the discovery of X-rays to the development of three-dimensional (3D) imagin...
Advances in biomedical engineering have led to three-dimensional (3D)-printed models being used for ...
Congenital heart disease (CHD) encompasses a heterogenous group of lesions whereby the anatomic stru...
Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross success...
With the rate of cardiovascular diseases in the U.S increasing throughout the years, there is a need...
Three-dimensional (3D) printing has become a widely used technique showing great promise in medical ...
Abstract Congenital heart diseases causing significant hemodynamic and functional cons...
Background: 3D technology support is an emerging technology in the field of congenital heart disease...
Congenital heart disease (CHD) is often comprised of complex three-dimensional (3D) anatomy that mus...
Congenital heart disease (CHD) is often comprised of complex three-dimensional (3D) anatomy that mus...
Patient-specific three-dimensional (3D) printed models have been increasingly used in cardiology and...
Three-dimensional (3D) printing has shown great promise in medicine with increasing reports in conge...
Echocardiography, CT and MRI have a crucial role in the management of congenital heart disease (CHD)...
Three-dimensional (3D) printing technology has become increasingly used in the medical field, with r...
Understanding the anatomical features and generation of realistic three-dimensional (3D) visualizati...
Abstract Beginning with the discovery of X-rays to the development of three-dimensional (3D) imagin...
Advances in biomedical engineering have led to three-dimensional (3D)-printed models being used for ...
Congenital heart disease (CHD) encompasses a heterogenous group of lesions whereby the anatomic stru...
Survival in congenital heart disease has steadily improved since 1938, when Dr. Robert Gross success...
With the rate of cardiovascular diseases in the U.S increasing throughout the years, there is a need...
Three-dimensional (3D) printing has become a widely used technique showing great promise in medical ...
Abstract Congenital heart diseases causing significant hemodynamic and functional cons...
Background: 3D technology support is an emerging technology in the field of congenital heart disease...